Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases

For decades, activation of Aryl Hydrocarbon Receptor (AhR) was excluded from consideration as a therapeutic approach due to the potential toxic effects of AhR ligands and the induction of the cytochrome P450 enzyme, Cyp1a1, following AhR activation. However, it is now understood that AhR activation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cannon, Alkeiver S., Nagarkatti, Prakash S., Nagarkatti, Mitzi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745713/
https://www.ncbi.nlm.nih.gov/pubmed/35008717
http://dx.doi.org/10.3390/ijms23010288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745713/
https://www.ncbi.nlm.nih.gov/pubmed/35008717
http://dx.doi.org/10.3390/ijms23010288

Ejemplares similares